Skip to main content

ETF Objective

The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Russell 2000 Index. The Fund will typically invest at least 80% of its assets to equity securities contained in the Index and/or financial instruments with similar economic characteristics.

Stock Chart

as of 4:10 PM ET 12/06/2021

Performance

  • 1 Week
  • -3.50%
  • 1 Month
  • -18.42%
  • 3 Months
  • -8.22%
  • 1 Yr Return
  • +30.53%
  • 5 Yr Return
  • +94.41%

Sector Breakdown

Financials 11.37%
Industrials 8.38%
Health Care 7.99%
Consumer Services 5.28%
Technology 5.13%
Consumer Goods 3.35%
Non Classified Equity 2.54%
Oil & Gas 2.15%
Basic Materials 1.74%
Utilities 1.18%

Geographic Exposure

Unidentified 50.58%
United States 47.83%
Bermuda 0.58%
United Kingdom 0.24%
Ireland 0.22%
Canada 0.14%
Puerto Rico 0.12%
Cayman Islands 0.07%
Singapore 0.06%
France 0.04%
Israel 0.03%
Monaco 0.03%
Luxembourg 0.02%
Germany 0.02%
Bahamas 0.01%
Panama 0.01%
Netherlands 0.01%
Switzerland 0.00%

Top 10 Holdings

Symbol Company Name % Of Assets
AMC AMC Entertainment Holdings Inc ORD 0.30%
ASAN Asana Inc ORD 0.16%
CROX Crocs Inc ORD 0.16%
OVV Ovintiv Inc ORD 0.16%
TTEK Tetra Tech Inc ORD 0.15%
LSCC Lattice Semiconductor Corp ORD 0.15%
NTLA Intellia Therapeutics Inc ORD 0.15%
CAR Avis Budget Group Inc ORD 0.14%
SLAB Silicon Laboratories Inc ORD 0.14%
M Macy's Inc ORD 0.14%

ETF Overview

Sponsor ProShares
iNav Ticker BVSY
Inception Date 01/23/2007
Name ProShares:Ult Rus2000
CUSIP 74347R842
Prospectus Date 10/01/2021

ETF Characteristics

Market Capitalization 3.63 B
Total Net Assets 281.10
Management Fee 0.69%
Administration Fee 0.14%
Asset Class Equity
Sub Asset Class Equity Leverage Funds
Number Of Holdings 2,031
Expense Ratio 0.95
Dividend n/a
Dividend Frequency Quarterly

LATEST NEWS

Recent Articles from TheStreet

New York Stock Exchange Lead

Intel Leads Tech Surge, Dow Futures Higher As Investors Look Past Omicron Risks

Wall Street looks set to recoup all -- and more -- of last week's Omicron-linked declines as investors look past risks tied to the new variant, which may be milder and less virulent that first anticipated.

retire wealth lifestyle garden sh

Will You Need Long-Term Care Insurance?

Your health and lifestyle needs can help you judge which long-term care insurance options are best for you. Here are four solutions.

American Airlines Lead

American Airlines CEO Doug Parker to Retire, Robert Isom Named New Boss

Doug Parker, American Airlines' long-serving CEO, will retire in March of next year, the carrier confirmed Tuesday.

Glaxo, IP and PetMed Poised to Go Higher

GlaxoSmithKline, Vir Biotechnology Say COVID Therapy Effective Against Omicron Variant

GlaxoSmithKline and its U.S. partner, Vir Biotechnology, said Tuesday that their COVID antibody is effective against all mutations of the new Omicron variant.

SpaceX founder and chief engineer Elon Musk (seen in January last year) joined Clubhouse on Monday, the same day stock rocketed by 30 per cent on Friday's closing price. Photo: Reuters

Tesla Stock Gains After Elon Musk Disses Biden's EV Bill

Tesla shares are set to snap a four-day losing streak after Elon Musk says Congress should not approve the Biden infrastructure bill that includes EV subsidies.

intel (4)

Intel Stock Surges On Plans For Potential $50 Billion Mobileye IPO

Intel plans to list Mobileye, the self-driving car division is purchased in 2017, sometime next year in a deal that could value the group at around $50 billion.

Omicron COVID-19 Lead

Investor Angst Over Omicron is Easing

James 'Rev Shark" Deporre says investors shouldn't ignore the latest variant.

Wall Street Diversity Lead

Intel, Samsung, Omicron, Tesla and Surging Stock Markets - 5 Things You Must Know

Stocks futures extend gains as Omicron risks fade, Glaxo and Vir Bio say COVID therapy effective against variant; Intel plans potential $50 billion Mobileye IPO; Samsung merges phone and electronics division in major restructuring and Elon Musk says Biden's EV incentives shouldn't pass congress.

Tech Companies Lead

Tech Stocks are Facing a Reckoning After Months of Rapid Gains

But some chip names still have relatively low valuations.